Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: - | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
The oral LD50 for FAT 41047/A TE is greater than 5000 mg/kg bw.
Key value for chemical safety assessment
Acute toxicity: via oral route
Link to relevant study records
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 2018
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 423 (Acute Oral toxicity - Acute Toxic Class Method)
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Test type:
- acute toxic class method
- Limit test:
- no
- Species:
- rat
- Strain:
- Wistar
- Sex:
- female
- Details on test animals or test system and environmental conditions:
- - Source:
In-Vivo Biosciences, Kodigehalli Village Magadi Road, Bangalore, Code-29, Karnataka State.
- Females (if applicable) nulliparous and non-pregnant: yes.
- Age at study initiation: 9 to 10 Weeks.
- Weight at study initiation: 180.8 to 214.5 g
- Fasting period before study: overnight.
- Housing: Rats were housed individually in standard polysulfone cages (size: approximately L 425 x B 266 x H 185 mm), with stainless steel top grill having facilities for pelleted food and drinking water in polycarbonate bottle. Additionally, polycarbonate rat huts were placed inside the cage as an enrichment object and were changed along with the cage once a week.
- Bedding: steam sterilized corn cob was used and changed once a week along with the cage.
- Diet: ad libitum
- Water: ad libitum
- Acclimation period: After physical examination for good health and suitability for experiment, the animals were acclimatized six days for G1-FTS, eight days for G1-STS, 10 days for G2-FTS and 12 days for G2- STS before treatment. Animals were observed once daily during acclimatization period.
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 20 to 24 °C
- Humidity (%): 65 to 67%
- Photoperiod (hrs dark / hrs light): 12 hours light and 12 hours dark cycle. - Route of administration:
- oral: gavage
- Vehicle:
- other:
- Remarks:
- 0.5% w/v sodium carboxymethyl cellulose (medium viscosity) with 1% v/v Tween 80 in Milli-Q water
- Details on oral exposure:
- Justification for choice of vehicle: Solubility and Suspend ability test was performed, the test item formed homogenous suspension with 0.5% w/v sodium carboxymethyl cellulose (medium viscosity) with 1% v/v Tween 80 in Milli-Q water. Hence, 0.5% w/v sodium carboxymethyl cellulose (medium viscosity) with 1% v/v Tween 80 in Milli-Q water was used as vehicle to prepare the dose formulations.
Dose selection:
Starting dose
There was no toxicology information available about the test item, hence the study was initiated with the starting dose of 300 mg/kg body weight (G1-FTS). The test was started as per Annex 2c of the OECD 423 test guideline.
Additional treatment groups
As there was no test item-related mortality observed at the starting dose of 300 mg/kg body weight (G1-FTS); the test was continued with same dosewith three additional female rats at second treatment step (G1-STS) and again with next two steps (G2-FTS & G2-STS) at the next higher dose of 2000 mg/kg body weight. The subsequent dosing was done at approximately 48 hours after the previous treatment step. - Doses:
- G1 - FTS : 300 mg/kg bw - Group 1, First test step.
G1 - STS : 300 mg/kg bw - Group 1, Second test step.
G2 - FTS : 2000 mg/kg bw - Group 2, First test step.
G2 - STS : 2000 mg/kg bw - Group 2, Second test step. - No. of animals per sex per dose:
- Three
- Control animals:
- no
- Details on study design:
- Duration of observation - 14 days
Frequency of observation : Animals were observed five times on test day 1 (day of administration) i.e. at 30 minutes and four times at hourly intervals and once daily during days 2 to 15 post administration.
Observations included changes in skin and fur, eyes and mucous membranes, and respiratory, circulatory, autonomic and central nervous systems and somatomotor activity and behavior pattern. Attention was directed to the observations of tremors, convulsions, salivation, diarrhea, lethargy, sleep and coma and all observed clinical signs were recorded.
The body weights were recorded on test day 1 (pre-administration), day 8 (7 days post administration) and day 15 (14 days post administration).
Necropsy : The rats surviving to the end of the observation period were euthanized by using isoflurane anesthesia and subjected to detailed necropsy. Microscopic examination was not carried out as no gross pathological changes were observed. - Key result
- Sex:
- female
- Dose descriptor:
- LD50
- Effect level:
- > 5 000 mg/kg bw
- Based on:
- test mat.
- Mortality:
- No mortality observed at 300 & 2000 mg/kg bw dose levels at any step.
- Clinical signs:
- No clinical signs were observed at any step.
- Body weight:
- The body weights of all the rats increased throughout the observation period.
- Gross pathology:
- There were no gross pathological findings at necropsy.
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- The LD50 for FAT 41047/A TE was found to be greater than 5000 mg/kg.
- Executive summary:
The acute oral toxicity study of FAT 41047/A TE to the Wistar rats was evaluated according to OECD 423 test guideline.
The dose formulation was prepared by using 0.5% w/v sodium carboxymethyl cellulose (medium viscosity) with 1% v/v Tween 80 in Milli-Q water and administered as a single oral gavage to overnight fasted (16 to 18 hours) three female rats (G1-FTS) at the dose of 300 mg/kg body weight (at a dose volume of 10 mL/kg body weight). There were no clinical signs and pre-terminal deaths.
Based on the scheme - Annex 2c, three additional female rats were tested at the same dose of 300 mg/kg body weight (G1-STS). There were no clinical signs and pre-terminal deaths. Additional three female rats were tested at next higher dose of 2000 mg/kg body weight (G2 -FTS).
There were no clinical signs and pre-terminal deaths. Hence, three additional female rats were tested at the same dose of 2000 mg/kg body weight (G2-STS). The rats were observed for mortality and clinical signs for 14 days post treatment. Body weights were recorded prior to dosing on day 1 and again on days 8 and 15. Necropsy was performed for all the rats at termination. All survived rats gained weight during experimental period. There were no gross pathological findings at necropsy.
Based on the results of the present study, the LD50for FAT 41047/A TE is greater than 5000 mg/kg as per the LD50cut-off value.
The test item does not meet the classification criteria as per Globally Harmonized Classification system as there were no mortality or clinical signs of toxicity observed at 5000 mg/kg body weight.
Reference
Dose (mg/kg body weight) | Rat No. | Sex | Body weight (Day 1) (g) | Total volume administered (mL) | Mortality |
G1 (FTS) 300 | Rm8101 | F | 187.5 | 1.88 | N |
Rm8102 | F | 214.5 | 2.15 | N | |
Rm8103 | F | 180.8 | 1.81 | N | |
G1 (STS) 300 | Rm8104 | F | 196.7 | 1.97 | N |
Rm8105 | F | 204.9 | 2.05 | N | |
Rm8106 | F | 202 | 2.02 | N | |
G2 (FTS) 2000 | Rm8107 | F | 201.8 | 2.02 | N |
Rm8108 | F | 199.6 | 2 | N | |
Rm8109 | F | 185.5 | 1.86 | N | |
G2 (STS) 2000 | Rm8110 | F | 188 | 1.88 | N |
Rm8111 | F | 201.6 | 2.02 | N | |
Rm8112 | F | 190.8 | 1.91 | N |
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- LD50
- Value:
- 2 000 mg/kg bw
- Quality of whole database:
- High quality GLP study
Acute toxicity: via inhalation route
Endpoint conclusion
- Endpoint conclusion:
- no study available
Acute toxicity: via dermal route
Endpoint conclusion
- Endpoint conclusion:
- no study available
Additional information
The acute oral toxicity of FAT 41047/A was assessed in a study conducted on Wistar rats according to OECD 423 test guideline. As no information regarding toxicity of FAT 41047/A was available, the initial dose was chosen to be 300 mg/kg bw as per the guideline. At each step, 3 female rats were used. No pre-terminal deaths and no clinical steps were observed at 300 mg/kg bw at first and second steps. Hence, additional testing at 2000 mg/kg bw was performed. Again, no pre-terminal deaths and no clinical signs were observed at these steps. Hence, the LD50 of FAT 41047 is estimated to be >5000 mg/kg bw.
Justification for classification or non-classification
FAT 41047/A was found to have low acute oral toxicity in the study conducted according to OECD TG 423, hence it does not warrant classification as per the Regulation (EC) No. 1272/2008.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.